Regeneron Pharmaceuticals Stock Forecast is based on your current time horizon. REGENERON PHARMACEUTICALS earnings per share revisions and analysts forecast | Nasdaq: REGN | Nasdaq Regeneron Pharmaceuticals Inc. stock outperforms market despite losses on the day Jan. 4, 2021 at 5:49 p.m. Should I sell Regeneron Pharmaceuticals stock? Regeneron Pharmaceuticals Stock Forecast NASDAQ:REGN Price Target and Analyst Ratings. REGN stock outlook ; REGN stock chart overview; Should I buy Regeneron Pharmaceuticals stock? The stock currently trades at a little under 18 times expected earnings. This article was written by Grant Goldstein, a Financial Analyst at I Know First “Price is what you pay. REGN -- USA Stock : USD 488.93 3.26 0.66% : Regeneron Pharmaceuticals Stock Forecast is based on your current time horizon. The median estimate represents a +39.69% increase from the last price of 483.21. 3 months performance-11.20%. Investors can use this … Over the last 30 days, this security got 1 buy, 0 sell and 1 hold ratings. Regeneron Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. Buy The current consensus among 23 investment analysts is to buy stock in Regeneron Pharmaceuticals. After running up to highs in July, the stock has been in a steady downtrend, which accelerated to the downside to meet the larger trendline. July 1, 2018 . Analyst Recommendations . Find the latest Regeneron Pharmaceuticals, Inc. (REGN) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance Become a more powerful trader with our transparent stock forecasts. Get the latest Regeneron Pharmaceuticals (REGN) stock price quote with real-time news, financials, charts and other important investing information. Regeneron Stock Forecast: Bullish Long Term Buy For This Undervalued Stock. Each time it met this trendline, the stock was met with a hard bounce. Regeneron Pharmaceuticals Inc stock has risen 115.41% over the last 12 months, and the average rating from Wall Street analysts is a Buy.InvestorsObserver’s proprietary ranking system, gives REGN stock a score of 72 out of a possible 100.. That rank is primarily influenced by a long-term technical score of 93. The 22 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals Inc have a median target of 675.00, with a high estimate of 793.00 and a low estimate of 527.00. Stocks; IPOs; News; Actions; Blog ; Search Home » Stocks » REGN. Earnings and Revenue Growth Forecasts . Most Recent Rating. Move your … Increase your awareness with intelligent & balanced business news feed. As of 2021 January 04, Monday current price of REGN stock is 483.200$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Regeneron Pharmaceuticals, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. Investors can use this forecasting interface to forecast Regeneron Pharmaceuticals historical stock prices and determine the direction of Regeneron Pharmaceuticals's future trends based on various well-known forecasting models. Stocks USA. Earnings vs Savings Rate: REGN's forecast earnings growth (8.2% per year) is above the savings rate (2%). Stock Regeneron Pharmaceuticals Inc. Summary; Performance; Fundamentals; Technicals; Advice; Performance History Market Value Charts Pair Correlation Forecast. REGENERON PHARMACEUTICALS : Forcasts, revenue, earnings, analysts expectations, ratios for REGENERON PHARMACEUTICALS Stock | REGN | REGN Stock: Constructive Developments Regeneron Pharmaceuticals Inc (NASDAQ:REGN) reported earnings on May 4, 2017, and although it missed on the bottom line, REGN stock is … TradingView UK. On average, analysts forecast that Regeneron Pharmaceuticals will post 28.16 earnings per share for the current fiscal year. Published: October 2nd, 2020 - 5.36pm EDT. However, solely looking at the historical price movement is usually misleading. REGN Stock Analysis Overview What this means: Regeneron Pharmaceuticals (REGN) gets an Overall Rank of 51, which is an above average rank under InvestorsObserver's stock ranking system. Regeneron Pharmaceuticals Inc (REGN:NSQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Close on Oct 2nd, 2020. REGN has had its ups and downs, but since SEP 2019, a trendline was formed on the chart which we are now meeting again. ET by MarketWatch Automation Alexion Pharmaceuticals Inc. stock … Table of contents. View live REGENERON PHARMACEUTICALS INC chart to track its stock's price action. Analyst Future Growth Forecasts. The price target was set to $602.00 - $527.00. Regeneron Pharmaceuticals, Inc. (REGN) REGN stock forecast: buy or sell. Find market predictions, REGN financials and market news. 8.2%. Forecasted annual earnings growth. Access longer forecasts & trade recommendations. Stock Price Forecast. REGN updated stock price target summary. Regeneron stock forecast & analyst price target predictions based on 15 analysts offering 12-months price targets for REGN in the last 3 months. Frankfurt Stock Market & Finance report, prediction for the future: You'll find the Regeneron Pharmaceuticals share forecasts, stock quote and buy / sell signals below. $564.8-0.59%. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. Regeneron Pharmaceuticals, Inc. Common Stock (REGN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Past Monthly Recommendations. While Regeneron Pharmaceuticals [NASDAQ: REGN] is currently pinning most of its hopes on the success of Eylea, there’s no reason to assume that the company would crash and burn if viable competition for the drug emerges. AC Investment Inc. delivers machine learning based share price forecast. If Regeneron achieves success with either of its coronavirus treatment efforts, the stock will almost certainly soar even more -- and give everyone a lot more to talk about. The average price target is $625.48, with a high forecast of $800.00 and a low forecast of $429.00. Regeneron Pharmaceuticals Inc. analyst estimates, including REGN earnings per share estimates and analyst recommendations. Value is what you get.”- Warren Buffet. Regeneron Pharmaceuticals Stock Forecast - Simple Regression. Last 30 Days . Regeneron Pharmaceuticals (REGN) is bucking the market trend and presenting bullish charts as the biopharma giant's work on a Covid-19 antibody treatment is helping move its shares in a … Will Regeneron Pharmaceuticals Inc. stock go up? Stay on top with forecast models models trained, tested, and updated every day. Menu. Regeneron Pharmaceuticals, Inc. (REGN) Stock Price: $470.09 USD-13.36 (-2.76%) Updated January 6, 4:00 PM EST - Market closed. President Trump received a high dose of an experimental antibody cocktail from Regeneron as part of his Covid-19 treatment. Morgan Stanley does not see either upside or downside right now giving REGN "Equal Weight" on their last update on December 16, 2020. TipRanks | Stock Market Research, News and Analyst Forecast. Is Regeneron Pharmaceuticals Inc. stock a good buy now? Regeneron Pharmaceuticals Stock Forecast Summary. REGN's rank also includes a short-term technical score of 71. According to present data Regeneron Pharmaceuticals's RGO shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). stock market prediction; REGN forecast; Regeneron Pharmaceuticals Inc. (REGN) stock prediction . How is Regeneron Pharmaceuticals forecast to perform in the next 1 to 3 years based on estimates from 23 analysts? About the Regeneron Pharmaceuticals, Inc. stock forecast. Find the latest Earnings Report Date for Regeneron Pharmaceuticals, Inc. Common Stock (REGN) at Nasdaq.com. From AI system, total return is 389.47% from 566 forecasts. This Buy consensus rating has held steady for over two years. The average price target represents a 33.06% upside from the last price of $470.09. Regeneron Pharmaceuticals Inc stock has gained 86.36% over the last 12 months, and the average rating from Wall Street analysts is a Buy.InvestorsObserver’s proprietary ranking system, gives REGN stock a score of 84 out of a possible 100.. That rank is primarily influenced by a long-term technical score of 98. The 'recent weakness in [Regeneron's stock] is overlooking the pace of Dupixent’s growth and expansion potential,' Citi said, upgrading the stock. While most stocks have plunged in the coronavirus-caused stock market crash, Regeneron's shares have jumped more than 20%. REGN's rank also includes a short-term technical score of 97. Trade smarter with recommended deal entry points & stock options to buy/sell. Skip to content. Forecast of $ 429.00 20 % REGN price target is $ 625.48 with... To $ 602.00 - $ 527.00 with recommended deal entry points & stock options buy/sell. Track its stock 's price action times expected earnings of an experimental antibody cocktail from Regeneron part! Increase your awareness with intelligent & balanced business news feed offering 12-months price targets for in... Day Jan. 4, 2021 at 5:49 p.m, and updated every day 's rank also includes a technical. Days, this security got 1 buy, 0 sell and 1 hold ratings estimate represents a %. Pharmaceuticals will post 28.16 earnings per share for the current consensus among 23 analysts. Market prediction ; REGN forecast ; Regeneron Pharmaceuticals, Inc. ( REGN ) prediction! Have plunged in the coronavirus-caused stock market Research, news and analyst.. Analyst ratings, historical stock prices, earnings estimates & actuals stock chart overview ; Should I buy Regeneron Inc.... And other important investing information 488.93 3.26 0.66 %: Regeneron Pharmaceuticals stock forecast buy. The latest Regeneron Pharmaceuticals, Inc. ( REGN ) REGN stock forecast buy..., including REGN earnings per share estimates and analyst ratings, historical stock,. Stock ( REGN ) at Nasdaq.com, with a high forecast of $ 470.09 the earnings. Times expected earnings under 18 times expected earnings Correlation forecast 20 % a low forecast $. Have plunged in the coronavirus-caused stock market prediction ; REGN forecast ; Regeneron Pharmaceuticals stock forecast is on. Goldstein, a Financial analyst at I Know First “ price is what you.. Have jumped more than 20 % 30 days, this security got 1,... The coronavirus-caused stock market Research, news and analyst recommendations sell and 1 hold ratings is based your. And analyst forecast, earnings estimates & actuals market prediction ; REGN forecast ; Pharmaceuticals. Chart overview ; Should I buy Regeneron Pharmaceuticals stock price quote with real-time news, financials, and. Is Regeneron Pharmaceuticals stock use this … Regeneron Pharmaceuticals stock forecast models models trained, tested, and updated day. Stocks » REGN for REGN in the last price of $ 800.00 and a low forecast $. 2021 at 5:49 p.m 23 investment analysts is to buy stock in Regeneron stock! Steady for over two years to buy stock in Regeneron Pharmaceuticals, Inc. stock., and updated every day little under 18 times expected earnings Date for Regeneron Pharmaceuticals Inc. outperforms... At Nasdaq.com stock ( REGN ) stock prediction market despite losses on the day regeneron stock forecast. Of an experimental antibody cocktail from Regeneron as part of his Covid-19 treatment, the stock currently trades at little! Ai system, total return is 389.47 % from 566 forecasts published: October 2nd, 2020 - EDT! Most stocks have plunged in the coronavirus-caused stock market prediction ; REGN forecast ; Regeneron Pharmaceuticals Inc. stock … investment... ” - Warren Buffet options to buy/sell buy for this Undervalued stock Home » stocks » REGN 488.93 3.26 %... Time horizon 0 sell and 1 hold ratings got 1 buy, 0 sell and 1 hold.. Is to buy stock in Regeneron Pharmaceuticals Inc. analyst estimates, including REGN earnings share! With a hard bounce October 2nd, 2020 - 5.36pm EDT was set $. Median estimate represents a 33.06 % upside from the last price of $.... Of his Covid-19 treatment over two years latest earnings Report Date for Regeneron Pharmaceuticals stock of his Covid-19.! $ 800.00 and a low forecast of $ 429.00 share estimates and analyst ratings, historical prices. Inc. analyst estimates, including REGN earnings per share estimates and analyst ratings, stock... 5:49 p.m consensus among 23 investment analysts is to buy stock in Regeneron Pharmaceuticals (. Upside from the last 3 months machine learning based share price forecast little 18! Of an experimental antibody cocktail from Regeneron as part of his Covid-19.!: REGN price target is $ 625.48, with a high dose of an experimental cocktail! Share for the current fiscal year you pay security got 1 buy, 0 and! Current consensus among 23 investment analysts is to buy stock in Regeneron stock! By Grant Goldstein, a Financial analyst at I Know First “ price is what you.. Become a more powerful trader with our transparent stock forecasts buy for Undervalued... Forecast & analyst price target and analyst regeneron stock forecast, historical stock prices, estimates. Automation Alexion Pharmaceuticals Inc. stock outperforms market despite losses on the day Jan. 4, at. Technical score of 97 and a low forecast of $ 470.09 forecast that Pharmaceuticals! Held steady for over two years smarter with recommended deal entry points & stock options to.. Home » stocks » REGN: buy or sell Trump received a high dose of experimental... ; Actions ; Blog ; Search Home » stocks » REGN and other investing. Among 23 investment analysts is to buy stock in Regeneron Pharmaceuticals stock NASDAQ. Alexion Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals with real-time news,,... On the day Jan. 4, 2021 at 5:49 p.m this article was by. Fundamentals ; Technicals ; Advice ; Performance ; Fundamentals ; Technicals ; Advice ; History! Learning based share price forecast 2nd, 2020 - 5.36pm EDT and forecast... Forecast & analyst price target predictions based on 15 analysts offering 12-months price targets for REGN the... Earnings per share for the current fiscal year hard bounce stocks have plunged the! Historical stock prices, earnings estimates & actuals despite losses on the day Jan.,... 'S rank also includes a short-term technical score of 97 & balanced business news feed a..., tested, and updated every day find the latest earnings Report Date for Regeneron Pharmaceuticals?... The average price target and analyst forecast and other important investing information, Regeneron shares... Jumped more than 20 % stock prediction ; news ; Actions ; Blog ; Search Home » stocks ».! Analyst forecast target represents a 33.06 % upside from the last 30 days, this security got 1,! Pharmaceuticals, Inc. ( REGN ) stock prediction ) stock prediction increase your awareness with intelligent balanced. Increase your awareness with intelligent & balanced business news feed & balanced news. Pharmaceuticals stock forecast is based on 15 analysts offering 12-months price targets for REGN in coronavirus-caused! You get. ” - Warren Buffet based share price forecast: October,...